Show simple item record

dc.contributor.authorMusatadi Larrucea, Mikel
dc.contributor.authorÁlvarez Mora, Iker
dc.contributor.authorBaciero Hernández, Inés
dc.contributor.authorAnakabe Iturriaga, Eneritz
dc.contributor.authorOlivares Zabalandikoetxea, Maitane
dc.contributor.authorExtebarria Loizate, Nestor
dc.contributor.authorZuloaga Zubieta, Olatz
dc.date.accessioned2024-04-16T15:14:40Z
dc.date.available2024-04-16T15:14:40Z
dc.date.issued2024-01-18
dc.identifier.citationTalanta 271 : (2024) // Article ID 125698es_ES
dc.identifier.issn0039-9140
dc.identifier.issn1873-3573
dc.identifier.urihttp://hdl.handle.net/10810/66709
dc.description.abstractPersistent, mobile and toxic substances have drawn attention nowadays due to their particular properties, but they are overlooked in human monitorization works, limiting the knowledge of the human exposome. In that sense, human urine is an interesting matrix since not only parent compounds are eliminated, but also their phase II metabolites that could act as biomarkers. In this work, 11 sample preparation procedures involving preconcentration were tested to ensure maximum analytical coverage in human urine using mixed-mode liquid chromatography coupled with high-resolution tandem mass spectrometry. The optimized procedure consisted of a combination of solid-phase extraction and salt-assisted liquid-liquid extraction and it was employed for suspect screening. Additionally, a non-discriminatory dilute-and-shoot approach was also evaluated. After evaluating the workflow in terms of limits of identification and type II errors (i.e., false negatives), a pooled urine sample was analysed. From a list of 1450 suspects and in-silico simulated 1568 phase II metabolites (i.e. sulphates, glucuronides, and glycines), 44 and 14 substances were annotated, respectively. Most of the screened suspects were diverse industrial chemicals, but biocides, natural products and pharmaceuticals were also detected. Lastly, the complementarity of the sample preparation procedures, columns, and analysis conditions was assessed. As a result, dilute-and-shoot and the Acclaim Trinity P1 column at pH =3 (positive ionization) and pH =7 (negative ionization) allowed the maximum coverage since almost 70 % of the total suspects could be screened using those conditions.es_ES
dc.description.sponsorshipThe authors acknowledge financial support from the State Research Agency of the Ministry of Science and Innovation, Government of Spain (project PID2020-117686RB-C31) and the Basque Government as a consolidated group of the Basque Research System (IT-1446-22). M. Musatadi and I. Baciero-Hernandez also acknowledge the Basque Government for their predoctoral fellowship. Lastly, I. Alvarez-Mora acknowledges the Basque Government for his postdoctoral fellowship as well.es_ES
dc.language.isoenges_ES
dc.publisherElservieres_ES
dc.relationinfo:eu-repo/grantAgreement/MCIN/PID2020-117686RB-C31es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectPersistent mobile and toxic substanceses_ES
dc.subjectexposomees_ES
dc.subjectphase II metaboliteses_ES
dc.subjectmix-mode liquid chromatographyes_ES
dc.subjecthigh resolution mass spectrometryes_ES
dc.subjectsuspect screeninges_ES
dc.titleSample preparation for suspect screening of persistent, mobile and toxic substances and their phase II metabolites in human urine by mixed-mode liquid chromatographyes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder© 2024 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND licensees_ES
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S0039914024000778es_ES
dc.identifier.doi10.1016/j.talanta.2024.125698
dc.departamentoesQuímica analíticaes_ES
dc.departamentoeuKimika analitikoaes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2024 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
Except where otherwise noted, this item's license is described as © 2024 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license